Cystic fibrosis transmembrane conductance regulator modulates enteric cholinergic activities and is abnormally expressed in the enteric ganglia of patients with slow transit constipation
- 315 Downloads
Cystic fibrosis transmembrane conductance regulator (CFTR) was recently found in the enteric nervous system, where its role is unclear. We aimed to identify which enteric neuronal structures express CFTR, whether CFTR modulates enteric neurotransmission and if altered CFTR expression is associated with slow transit constipation (STC).
Immunofluorescence double labeling was performed to localize CFTR with various neuronal and glial cell markers in the human colon. The immunoreactivity (IR) of CFTR and choline acetyltransferase (ChAT) on myenteric plexus of control and STC colon was quantitatively analyzed. In control colonic muscle strips, electrical field stimulation (EFS) evoked contractile responses and the release of acetylcholine (ACh) was measured in the presence of the CFTR channel inhibitor, CFTR(inh)-172.
CFTR-IR was densely localized to myenteric ganglia, where it was co-localized with neuronal markers HuC/D and β-tubulin, and glial marker S-100 but little with glial fibrillary acidic protein. Vesicular ACh transport was almost exclusively co-localized with CFTR, but neurons expressing nitric oxide synthase were CFTR negative. Significant reductions of CFTR-IR (P < 0.01) and ChAT-IR (P < 0.05) were observed on myenteric ganglia of STC compared to control. Pre-treatment of colonic muscle strips with CFTR(inh)-172 (10 µM) significantly inhibited EFS-evoked contractile responses (P < 0.01) and ACh release (P < 0.05).
Co-localization of CFTR-IR with cholinergic markers, inhibition of EFS-induced colonic muscle contractility and ACh release by CFTR(inh)-172 suggest that CFTR modulates enteric cholinergic neurotransmission. The downregulation of CFTR and ChAT in myenteric ganglia of STC correlated with the impaired contractile responses to EFS.
KeywordsCFTR Motility disorder Slow transit constipation
This study was supported by a project Grant from the National Health and Medical Research Council of Australia (APP1048885), and by the UNSW and Shanghai Jiao Tong University Collaborative Seed Grant. We would like to offer our special thanks to Stelina Drimousis and Erica Diezmos in specimen collection and preparation.
Compliance with ethical standards
Conflict of interest
There are no conflicts of interest.
- 7.Su M, Guo Y, Zhao Y, et al. Expression of cystic fibrosis transmembrane conductance regulator in paracervical ganglia this paper is one of a selection of papers published in this special issue entitled “Second International Symposium on Recent Advances in Basic, Clinical, and Social Medicine” and has undergone the journal's usual peer review process. Biochem Cell Biol. 2010;88:747–55.CrossRefPubMedPubMedCentralGoogle Scholar
- 18.Liu L, Shang F, Morgan MJ, et al. Cyclooxygenase-dependent alterations in substance P-mediated contractility and tachykinin NK1 receptor expression in the colonic circular muscle of patients with slow transit constipation. J Pharmacol Exp Ther. 2009;329:282–9.CrossRefPubMedPubMedCentralGoogle Scholar
- 54.Cil O, Phuan PW, Son JH, et al. Phenylquinoxalinone CFTR activator as potential prosecretory therapy for constipation. Transl Res. 2017;182(14–26):e4.Google Scholar